Bicycle Therapeutics Plc
(NASDAQ) BCYC
Bicycle Therapeutics Plc Financials at a Glance
Market Cap
$246.65M
Revenue (TTM)
$72.59M
Net Income (TTM)
$218.96M
EPS (TTM)
$-3.17
P/E Ratio
-1.56
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$4.94
Volume
18,084
Open
$4.92
Price
$4.94
Volume
18,084
Open
$4.92
Previous Close
$4.94
Daily Range
$4.88 - $5.00
52-Week Range
$4.24 - $9.55
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$4.94
Volume
18,084
Open
$4.92
Previous Close
$4.94
Daily Range
$4.88 - $5.00
52-Week Range
$4.24 - $9.55
BCYC News
Is Bicycle Therapeutics Stock a Buy?
BCYC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bicycle Therapeutics Plc
Industry
Biotechnology
Sector
Health CareEmployees
288
CEO
Kevin Lee, PhD, MBA
Website
bicycletherapeutics.comHeadquarters
Cambridge, CB22 3AT, GB
BCYC Financials
Key Financial Metrics (TTM)
Gross Margin
-1%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-31%
Return on Capital
-37%
Return on Assets
-31%
Earnings Yield
-64.10%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$246.65M
Shares Outstanding
49.93M
Volume
18.08K
Short Interest
0.00%
Avg. Volume
441.13K
Financials (TTM)
Gross Profit
$72.59M
Operating Income
$247.06M
EBITDA
$276.86M
Operating Cash Flow
$249.68M
Capital Expenditure
$2.36M
Free Cash Flow
$252.61M
Cash & ST Invst.
$628.11M
Total Debt
$17.52M
Bicycle Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$47.95M
+1193.3%
Gross Profit
$12.90M
+124.6%
Gross Margin
26.89%
N/A
Market Cap
$246.65M
N/A
Market Cap/Employee
$808.70K
N/A
Employees
305
N/A
Net Income
$20.15M
+61.1%
EBITDA
$29.74M
+54.9%
Quarterly Fundamentals
Net Cash
$610.59M
-29.8%
Accounts Receivable
$35.59M
-0.2%
Inventory
$0.00
N/A
Long Term Debt
$14.77M
+270.1%
Short Term Debt
$2.76M
-49.9%
Return on Assets
-30.51%
N/A
Return on Invested Capital
-37.39%
N/A
Free Cash Flow
$17.24M
-76.5%
Operating Cash Flow
$19.01M
-103.1%